Category diabetes drugs

PLEASE NOTE: MEDICINAL PRODUCT IS NO LONGER AUTHORIZED What is Liprolog? Liprolog includes a series of injectable solutions and suspensions. It is supplied in vials, cartridges or pre-filled pens (Liprolog Pen and Liprolog KwikPen). Insulin lispro is the active ingredient in the medicine. The Liprolog range includes fast-acting insulin solutions (Liprolog), long-acting insulin suspensions (Liprolog Basal) and combinations of both in different dosages (Liprolog Mix): Liprolog: insulin lispro solution; Liprolog Basal: suspension of insulin lispro protamine; Liprolog Mix25: 25% insulin lispro solu

What is Lusduna - Insulin Glargine and what is it used for? Lusduna is a medicine used in patients at least 2 years of age to treat diabetes. It contains the active substance insulin glargine. Lusduna is a "biosimilar medicine". This means that Lusduna is very similar to a biological medicine (also known as a 'reference medicine') that has already been authorized in the European Union (EU)

What is Lyxumia - Lixisenatide? Lyxumia is a medicine containing the active substance lixisenatide. It is available as a solution for injection in pre-filled pens of 10 micrograms or 20 micrograms of lixisenatide per dose. What is Lyxumia - Lixisenatide used for? Lyxumia is indicated for the treatment of adult patients with type 2 diabetes to control blood glucose (sugar) levels

METFORAL ® is a drug based on Metformin Hydrochloride THERAPEUTIC GROUP: Oral anti-diabetics IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications METFORAL ® Metformin METFORAL ® is indicated both in monotherapy and in combination therapy, in the treatment of type II diabetes, not corrected by a balanced diet and a normal lifestyle. M

MINIRIN / DDVAP ® is a drug based on Desmopressin THERAPEUTIC GROUP: Hormones of the posterior pituitary lobe IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications MINIRIN / DDVAP ® - Desmopressin MINIRIN / DDVAP ® is used in the treatment of diabetes insipidus, primary nocturnal enuresis, post-operative polyuria and nocturia associated with multiple sclerosis. D

MINIDIAB ® a drug based on Glipizide. THERAPEUTIC GROUP: Oral hypoglycemic agents - Sulfonylureas IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications MINIDIAB ® - Glipizide MINIDIAB ® is used as a pharmacological aid in type II diabetic patients, when diet and exercise are not sufficient to guarantee good glycemic control. M

What is Mixtard? Mixtard is a series of injectable insulin suspensions. Mixtard is available in vials, cartridges (Penfill) or pre-filled pens (NovoLet, FlexPen or InnoLet). The active substance in Mixtard is human insulin (DNAr). Mixtard is a mixture of fast-acting (soluble) insulin and long-acting insulin (isophane)

PLEASE NOTE: MEDICINAL PRODUCT IS NO LONGER AUTHORIZED MONOTARD ® a drug based on insulin zinc human suspension THERAPEUTIC GROUP: Insulin zinc human suspension for injectable use - insulins and analogues IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications MONOTARD ® - Insulin zinc human suspension MONOTARD ® is indicated for the treatment of insulin dependent diabetic patients. M

NOVOMIX ® a drug based on soluble insulin as protamine-crystallized insulin aspart THERAPEUTIC GROUP: Biphasic insulin for injectable use - insulins and analogues IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications NOVOMIX ® Insulin soluble aspart + protamine-crystallized insulin aspart NOVOMIX ® indicated in the treatment of diabetic pathology that requires insulin therapy. M

What is NovoMix? NovoMix includes a series of injectable suspensions, available in cartridges or in pre-filled pens. NovoMix contains the active substance insulin aspart 100 units (U) per milliliter in the following ratio: • NovoMix 30: 30% soluble insulin aspart (fast action) and 70% protamine-crystallized insulin aspart (prolonged action); • NovoMix 50: 50% of soluble insulin aspart (fast action) and 50% of protamine-crystallized insulin aspart (prolonged action); • NovoMix 70: 70% soluble insulin aspart (fast action) and 30% protamine-crystallized insulin aspart (prolonged action). What